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1. Data {#sec1}
=======

A sequence of procedures is presented in [Fig. 1](#fig1){ref-type="fig"}.Fig. 1Pipeline for an AFM detection of target proteins specifically caught from the blood solution on the AFM-chip surface.Fig. 1

Early in our works we have showed, that the amount of nonspecifically sorbed protein on the surface is more than 2 times less than that obtained due to the affinity interaction of aptamer/antigen [@bib2], [@bib5].

Standard MALDI MS spectrum obtained for a working AFM-chip after incubation in the blood serum sample containing HCV RNA (by PCR) is shown in [Fig. 2](#fig2){ref-type="fig"}.Fig. 2Standard mass spectrum of objects formed on the AFM-chip after incubation in the blood serum sample containing HCV RNA (by PCR). Black circles mark peaks of trypsin autolysis, black triangles -- antigen peptides, S/N marks values corresponding to signal/noise ratio.Fig. 2

The analysis of peptide maps taking into consideration the modifications of peptides HCVcoreAg with ions of K+, Na+ and their CL-- ions, obtained for positive blood serum samples, demonstrated an increase in the number of identified peptides of the target protein 3 peptides on average ([Table 1](#tbl1){ref-type="table"}).Table 1Frequency of cation-modified peptides within HCVcoreAg in 19 blood serum samples positive for HCV RNA (by PCR).Table 1Amino acidAmino acid residuesm/zFrequency peptide-cationNa+K+Na~2~CLK~2~CLRGPRLGVR40--47910,52ATRKTSER48--55948,54GRRQPIPK60--67951,52TSERSQPR52--59960,45RQPIPKAR62--69965,661KTNRNTNR42--471003,65MSTNPKPQK41--471030,53GPRLGVRATR41--501082,65KTSERSQPR51--591088,61MSTNPKPQKK41--481158,61TSERSQPRGR52--611173,63418GSRPSWGPTDPR102--1131312,711QPIPKARQPEGR63--741376,75GSRPSWGPTDPRR102--1141468,711MSTNPKPQKKTNR41--511529,81GSRPSWGPTDPRRR102--1151624,811FPGGGQIVGGVYLLPR24--391629,932FPGGGQIVGGVYLLPRR24--401786,0626

The MALDI MS analysis of protein composition on AFM-chip surface with immobilized aptamers after incubation in 19 samples of blood serum samples positive for HCV RNA by PCR allowed for reliable detection of the target protein in 11 blood serum samples, whereas for 8 blood serum samples the detected number of peptide fragments of HCVcoreAg was insufficient for reliable identification. In MALDI MS false negative samples (the bar-zone in [Fig. 3](#fig3){ref-type="fig"}) were detected for up to 4 peptide fragments of the target proteins (See [Supplementary Fig. 2](#appsec2){ref-type="sec"}). However, as it is clear from [Fig. 3](#fig3){ref-type="fig"} the average of 3--5 cation-modified fragments of target protein were detected for most of samples.Fig. 3Tukey box plot of the increase in the number of identified peptides of HCVcoreAg due to peptides that capture potassium (A), sodium (B), and both (C). All p-values are from paired T-test for a difference in means.Fig. 3

2. Experimental design, materials and methods {#sec2}
=============================================

*Reagents:* Dulbecco\'s phosphate buffered saline (DPBS, 10 mM*,* pH 7.4) (Pierce, USA); crosslinker 3,3′-dithiobis(sulfosuccinimidyl propionate) (DSP) (ТermoScientific, USA); (3-Aminopropyl)triethoxysilane (APTES), ammonium bicarbonate and dimethyl sulfoxide (DMSO) (Sigma-Aldrich, США); 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), N-Hydroxysuccinimide (NHS), acetonitrile, isopropanol, formic acid (Merck, USA); trifluoroacetic acid (TFA), α-cyano-4-hydroxycinnamic acid (HCCA) (Sigma, USA); trypsin (Promega, USA); phosphate buffered saline concentrate with 0.05% tween-80 (Vector-Best, Russia). Solutions were made using the distilled water that were additionally treated with Milli-Q deionizer (Millipore, USA).*Aptamers* of four types against HCVcoreAg of at least 99% purity were purchased from Evrogen JSC (Russia). The sequences of NH~2~-(T) 10-Aptamer types are presented below.Aptamer\'s nameAptamer sequenceА125′--NH~2~--(T)~10~- ACGCTCGGATGCCACTACAGGCACGCCAGACCAGCCGTCCTCTCTTCATCCGAGCCTTCACCGAGCCTCATGGACGTGCTGGTGA-3′А145′--NH~2~--(T)~10~- ACGCTCGGATGCCACTACAGTAACACACACAACTTAAAATCATACAAAAAAGAGTAAATGCCTCATGGACGTGCTGGTGA-3′А155′--NH~2~--(T)~10~- ACGCTCGGATGCCACTACAGCCAAATACTACCGCAAAAACCACCTCCCCCTCGATAATAGCCTCATGGACGTGCTGGTGA-3′А165′--NH~2~--(T)~10~- ACGCTCGGATGCCACTACAGTACCACACATGCAGACCCACACAAATACATACTAGAGACACCTCATGGACGTGCTGGTGA-3′

The thymine amino group and ten nucleotides were included into the nucleotide sequences of aptamers to improve its covalent immobilization efficiency on the surfaces of the AFM-chip, and to level up steric hindrances in interaction with target protein molecules [@bib3].

*Serum samples* were kindly provided by the Department of Infectious Diseases in Children No. 1 of Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia and G.N. Gabrichevsky Moscow Scientific Research Institute of Epidemiology and Microbiology of CPS of Russia. All serum samples were previously tested for the presence of HCV markers (HCV RNA, by PCR). Content of HCV RNA in patient serum presupposes intensive replication of virus in hepatocytes and hence, production and excretion of viral particles and HCV proteins in blood. From the PCR, all serum samples containing HCV RNA were considered to be HCV-positive. The patients gave their voluntary informed consent for participation in the study and use of their biomaterial.

2.1. Preparation of the AFM-Chip {#sec2.1}
--------------------------------

Mica by SPI Inc. (USA), characterized by maximum surface elevation difference of up to 0.5 nm was used as AFM-chip. Four zones with immobilized aptamers (А12, А14, А15 and А16) were formed on the surfaces of working and control AFM-chips. Activation of the AFM-chip surfaces and immobilization of aptamers were carried out in accordance with the method detailed in article [@bib3]. Arrangement of zones on the AFM-chip surfaces is presented in [Supplementary Fig. 1](#appsec2){ref-type="sec"}. Working AFM-chips were incubated in blood serum samples containing HCV RNA by PCR whereas, control AFM-chips were incubated in blood serum samples from healthy volunteers.

To carry out specific enrichment of HCVcoreAg the AFM-chip with immobilized aptamers was incubated for 30 min in 1 mL of blood serum sample with vigorous mixing (850 r/min) in Thermomixer Comfort Shaker ("Eppendorf", Germany) at 25 °C. Subsequently, the AFM-chip was washed thrice with deonized water for 30 minutes at 37 °C and dried in presence of nitrogen flow. Emulgen 913 solution at a concentration of 0.01% that has been used in our previous study [@bib3], [@bib4] was used as the wash buffer.

To control efficiency of working AFM-chip surfaces enrichment, NTEGRA Prima atomic force microscope by NT-MDT (Zelenograd, Russia), AppNano cantilevers (USA), ACSTA model were employed in the study. A detailed description of AFM-measurements and procedure for scanning process are presented in the article [@bib3], [@bib4].

2.2. Sample preparation of the AFM-Chip for mass spectrometry measurements {#sec2.2}
--------------------------------------------------------------------------

Working and control AFM-chips were cut along the contour of zones into four fragments corresponding to the zones of each aptamer and placed into individual marked Eppendorf\'s of 1.5 mL in volume. Trypsinolysis of protein objects on the surface of each zone of AFM-chip was carried out directly in marked Eppendorf\'s, into which 70 mcL of incubation solution including 1% acetonitrile, 0.1 μM of modified trypsin in 100 mM (рН 7.4) of bicarbonate buffer was added. Followed by the desalination of mixture with peptide fragments using Millipore ZipTip С18 (Sigma, USA) as per the manufacturer\'s protocol and supplied to the time-of-flight mass-spectrometer for measurements [@bib6], [@bib7].

2.3. Mass spectrometry measurements {#sec2.3}
-----------------------------------

Proteins identification was carried out using Autoflex III time-of-flight mass-spectrometer (Bruker, Germany), equipped with nitrogen laser with emission wavelength of 337 nm. Calibration of mass spectrometer was performed using the peptide calibration standard for positive ions in the reflector mode with voltage of 3.5--4.0 kV, the recorded mass spectrum was 750--3000 m/z with a pulse delay time of 200 ns. The peptide calibration standard was represented with following peptides (monoisotolic single-protonated ionic mass), bradykinin (757.3992 Da), angiotensin II (1046.5420 Da), angiotensin I (1296.6853 Da), R peptide (1347.7361 Da), bombesin (1619.8230 Da), renin (1758.9326 Da), ACTH fragment 1--17 (2093.0868 Da), ACTH fragment 18--39 (2465.1990 Da), and somatostatin (3147.4714 Da). The spectrum analysis excluded the peaks of trypsin matrix and autolysis. The mass spectrum was accumulated in auto mode until the sample spread on target was exhausted (usually 50,000 shots). To obtain mass spectra of the samples, the hydrolyzed mixture was mixed with excessive matrix (HCCA in 50% acetonitrile solution in 0.7% TFA) at the ratio ranging from 1:1000 to 1:10,000 and the resulting mixture was spread on MTP AnchorChip 384 target [@bib6], [@bib7], [@bib8].

The mass spectra were processed with flexAnalysis 2.0 (Bruker, Germany). The protein identification was performed with Mascot proteomic search engine (<http://www.matrixscience.com>) using the protein sequencing data library SwissProt_2012. The following search options were selected: taxonomic group -- hepatitis C virus, 2-missed hydrolysis sites, the acceptable measurement accuracy of monoisotopic masses was less than 100 ppm, methionine oxidation was indicated as a possible modification [@bib5].
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